Follow
L.C. Steggink
L.C. Steggink
Erasmus MC
Verified email at erasmusmc.nl - Homepage
Title
Cited by
Cited by
Year
Cardio-oncology: progress in diagnosis and treatment of cardiac dysfunction.
J Tromp, LC Steggink, DJ Van Veldhuisen, JA Gietema, P Van der Meer
Clinical pharmacology and therapeutics 101 (4), 481-490, 2017
422017
Myocardial dysfunction in long‐term breast cancer survivors treated at ages 40–50 years
JN Jacobse, LC Steggink, GS Sonke, M Schaapveld, YM Hummel, ...
European journal of heart failure 22 (2), 338-346, 2020
312020
Vascular aging in long-term survivors of testicular cancer more than 20 years after treatment with cisplatin-based chemotherapy
J Stelwagen, S Lubberts, LC Steggink, G Steursma, LM Kruyt, ...
British journal of cancer 123 (11), 1599-1607, 2020
262020
Cardiac Function After Radiation Therapy for Breast Cancer
VAB van den Bogaard, P van Luijk, YM Hummel, P van der Meer, E Schuit, ...
International Journal of Radiation Oncology* Biology* Physics 104 (2), 392-400, 2019
262019
High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer and 4 or More Involved Axillary Lymph Nodes: 20-Year Follow-up of a …
TG Steenbruggen, LC Steggink, CM Seynaeve, JJM van der Hoeven, ...
JAMA oncology, 2020
172020
Physical activity and cardiac function in long-term breast cancer survivors: a cross-sectional study
WR Naaktgeboren, WG Groen, JN Jacobse, LC Steggink, ...
Cardio Oncology 4 (2), 183-191, 2022
152022
Survival in anaplastic thyroid cancer in relation to pre-existing goiter: a population-based study
LC Steggink, BAC van Dijk, TP Links, JTM Plukker
The American Journal of Surgery 209 (6), 1013-1019, 2015
132015
Genome-wide association study of cardiovascular disease in testicular cancer patients treated with platinum-based chemotherapy
LC Steggink, H Boer, C Meijer, JD Lefrandt, LWMM Terstappen, ...
The pharmacogenomics journal 21 (2), 152-164, 2021
72021
Insulin‐like factor 3, luteinizing hormone and testosterone in testicular cancer patients: effects of β‐hCG and cancer treatment
LC Steggink, AP van Beek, H Boer, C Meijer, S Lubberts, SF Oosting, ...
Andrology 7 (4), 441-448, 2019
62019
Life expectancy 20 years after cisplatin-based treatment for testicular cancer (TC).
S Lubberts, LM Kruyt, LC Steggink, G Steursma, J Nuver, S Oosting, ...
Journal of Clinical Oncology 35 (15_suppl), 4550-4550, 2017
32017
Vascular damage and pulmonary function in very long-term survivors of testicular cancer (TC) treated with cisplatin-based chemotherapy (CT)
J Stelwagen, S Lubberts, LC Steggink, G Steursma, LM Kruyt, ...
Annals of Oncology 29, viii324, 2018
22018
Adjuvant aromatase inhibitor therapy and early markers for cardiovascular disease in breast cancer survivors
A van Ommen-Nijhof, JN Jacobse, LC Steggink, JD Lefrandt, JA Gietema, ...
Breast Cancer Research and Treatment 196 (3), 591-602, 2022
12022
Prognostic Factors and Survival in Anaplastic Thyroid Cancer: A Population-based Study in North-East Netherlands
JT Plukker, L Steggink, B Van Dijk
Annals of Surgical Oncology 20, S85, 2013
12013
A woman with skin abnormalities and muscle weakness
LC Steggink, ME Hettema, CE Delsing
Nederlands tijdschrift voor geneeskunde 157 (30), A6306-A6306, 2013
12013
Predictive value of ectopic HORMAD1 tumor expression for high-dose platinum-based chemotherapy benefit in patients with high-risk HER2-negative breast cancer.
L De Boo, J Quist, M Opdam, K Jozwiak, P Gazinska, D Peters, ...
Journal of Clinical Oncology 40 (16_suppl), 541-541, 2022
2022
Adjuvant aromatase inhibitor therapy and early markers for cardiovascular disease in breast cancer survivors
AVO Nijhof, JN Jacobse, LC Steggink, JD Lefrandt, JA Gietema, ...
2022
Physical Activity and Cardiac Function in Long-Term Breast Cancer Survivors
WR Naaktgeboren, WG Groen, JN Jacobse, LC Steggink, ...
2022
Long-term outcome and treatment-related toxicity in patients with breast and testicular cancer
L Steggink
2022
High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer—Reply
TG Steenbruggen, LC Steggink, GS Sonke
JAMA oncology 6 (8), 1300-1300, 2020
2020
High-dose chemotherapy (HDCT) with hematopoietic stem cell transplantation (HSCT) in high-risk breast cancer (BC) patients with≥ 4 involved axillary lymph nodes (ALN): 20-year …
TG Steenbruggen, LC Steggink, CM Seynaeve, JJM van der Hoeven, ...
Annals of Oncology 29, viii59, 2018
2018
The system can't perform the operation now. Try again later.
Articles 1–20